Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(2-Pyridyl)piperazine → N-(3,4-Dichlorophenyl)-7-[(2E)-4-(4-pyridin-2-ylpiperazin-1-yl)but-2-enoyl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(2-Pyridyl)piperazine | HCID 94459 | — |
| 반응물 | 7-[(2E)-4-Chlorobut-2-enoyl]-N-(3,4-dichlorophenyl)-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine | HCID 58116806 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | N-(3,4-Dichlorophenyl)-7-[(2E)-4-(4-pyridin-2-ylpiperazin-1-yl)but-2-enoyl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine | HCID 25221097 | 79.7% |
반응 단계
To a suspension of Example 59A (80 mg, 0.16 mmol) in DMF (1 mL) was added 1-pyridin-2-ylpiperazine (52 mg, 0.32 mmol), and the mixture was stirred at rt for 3 h and then heated to 50° C. for 4 h. After purification by preparative HPLC, the product crystallized upon trituration with dichloromethane to yield 74 mg (79%) of the title compound.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08524722B2 |
| 출처 데이터셋 | uspto-grants-2013_09 |
| ORD ID | ord-8b0cbf93ec1948008fc11b3cfa0b0809 |
| 출처 메모 | uspto-grants-2013_09 |